Diabetes is the chronic condition associated with abnormally high level of glucose in the blood. Insufficient or non production of insulin in pancreas causes diabetes.

1. Diabetic Retinopathy Market : Size, Share, Development, Growth and Demand
Forecast to 2014 - 2020
Persistence Market Research
Diabetic Retinopathy Market : Size, Share,
Development, Growth and Demand Forecast
to 2014 - 2020
Persistence Market Research 1

2. Diabetic Retinopathy Market : Size, Share, Development, Growth and Demand
Forecast to 2014 - 2020
Persistence Market Research Released New Market Report on “Diabetic Retinopathy
Market : Size, Share, Development, Growth and Demand Forecast to 2014 - 2020”.
Diabetes is the chronic condition associated with abnormally high level of glucose in the blood.
Insufficient or non production of insulin in pancreas causes diabetes. Globally, the incidence of
diabetes is increasing significantly and it is becoming a major burden. According to the
International Diabetes Federation in 2013, approximately 382 million people currently suffer
from diabetes across the world. Diabetic retinopathy is the most common complication of
diabetic that affects eyes. People suffering from diabetes type I and II have risk of developing
diabetic retinopathy. It is caused due to change in blood vessels i.e. swelling or leakage of blood
vessels of retina. Retina is thin layer of light sensitive tissue at the back of the eye. In initial
stages diabetic retinopathy may not show any symptoms and later may lead to severe vision
loss. Proliferated and non-proliferated are the major stages of diabetic retinopathy. Proliferated
diabetic retinopathy is the most dangerous stage. Proliferated diabetic retinopathy has the risk
of detachment or hemorrhage into the vitreous leading to severe vision loss. Diabetic
retinopathy is treated by many ways depending upon the stage of diabetic retinopathy. It is one
of the leading causes of blindness in American adults. According to WHO estimates, in 2012,
347 million people were suffering from diabetes globally, of which 11% had diabetic retinopathy.
In the U.S., diabetic retinopathy affected around 4.1 million people, while vision-threatening
retinopathy was estimated to have affected 899,000 people, in 2010. Diabetic retinopathy is
treated with the help of medications and surgeries such as vitrectomy. In addition, control in
levels of diabetes is also essential for the treatment of diabetic retinopathy.
Interested in report: Please follow the below the links to meet your requirements;
Request for the Report Sample:http://www.persistencemarketresearch.com/samples/3463
North America dominates the global market for diabetic retinopathy due to large number of
aging population. Asia is expected to show high growth rates in the next five years in the global
diabetic retinopathy market. China and India are expected to be the fastest growing diabetic
retinopathy markets in Asia-Pacific region. Some of the key driving forces for diabetic
retinopathy market in emerging countries are large pool of patients and rising government
support and funding.
In recent times there is increase in diabetic retinopathy due to increasing prevalence of
diabetics. Global aging population and change in lifestyle are some of the key factors driving the
growth for the global diabetic retinopathy market. In addition, increasing healthcare awareness
is also fuelling the growth of global diabetic retinopathy market. However, lack of accurate
Persistence Market Research 2

3. Diabetic Retinopathy Market : Size, Share, Development, Growth and Demand
Forecast to 2014 - 2020
diagnosis of the disease and poor primary healthcare infrastructure and lack of insurance are
some of the major factors restraining the growth for the global diabetic retinopathy market.
Request TOC (table of content), Figures and Tables of the Report:
http://www.persistencemarketresearch.com/toc/3463
Rising initiatives towards healthcare infrastructure would lead to growth in diabetic retinopathy
market in Asia. Some of the trends for the global diabetic retinopathy market are increase in
awareness of diabetic retinopathy treatment and increase use of electronic medical record in
ophthalmology. Some of the major companies operating in the global diabetic retinopathy
market are Novartis AG., F. Hoffmann-La Roche Ltd., Bayer AG, Pfizer, Inc., Allergan Inc., Isis
Pharmaceuticals, Inc., Valeant Pharmaceuticals, Inc., Abbott Laboratories, Inc. and Regeneron
Pharmaceuticals, Inc.
Key points covered in the report
1) Report segments the market on the basis of types, application, products, technology, etc (as
applicable)
2) The report covers geographic segmentation
North America
Europe
Asia
RoW
3) The report provides the market size and forecast for the different segments and geographies
for the period of 2010 to 2020
4) The report provides company profiles of some of the leading companies operating in the
market
5) The report also provides porters five forces analysis of the market.-
PMR for Journalist: http://www.persistencemarketresearch.com/page/journalist-resources.asp
About Us
Persistence Market Research 3

4. Diabetic Retinopathy Market : Size, Share, Development, Growth and Demand
Forecast to 2014 - 2020
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses
achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-
disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources.
By deploying real-time data collection, big data, and customer experience analytics, we deliver
business intelligence for organizations of all sizes.
Contact
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
Persistence Market Research 4